{"Literature Review": "The study of immunology in both mice and humans has been a cornerstone of understanding infectious diseases and immune responses. However, the translational gap between findings in murine models and human clinical observations has been a persistent challenge. This literature review aims to explore the genetic underpinnings that reconcile these differences, focusing on the genetic susceptibility to infectious diseases and inborn errors of immunity. \n\nMouse models have been instrumental in dissecting the genetic basis of immune responses due to their genetic tractability and the ability to control environmental variables. The use of genetically modified mice has provided insights into the roles of specific genes in immune function and disease susceptibility (Shultz et al., 2007). However, the extrapolation of these findings to humans is often met with skepticism due to species-specific differences in immune system architecture and pathogen exposure (Mestas and Hughes, 2004). For instance, the expression and function of Toll-like receptors (TLRs), which are critical for pathogen recognition, differ significantly between mice and humans, leading to divergent immune responses (Seok et al., 2013). \n\nConversely, human studies, particularly those involving patients with inborn errors of immunity, offer direct insights into the genetic basis of immune function. These studies have identified numerous genetic mutations that confer susceptibility to specific infections, providing a direct link between genotype and phenotype (Casanova et al., 2013). However, the complexity of human genetics, coupled with environmental and lifestyle factors, often complicates the interpretation of these findings. The small sample sizes and uncontrolled conditions typical of human studies further limit their generalizability (Cooper et al., 2015). \n\nThe genetic perspective offers a framework for reconciling these differences. Forward genetics, which involves identifying genes responsible for a phenotype, has been particularly successful in both mice and humans. For example, the identification of the IFNGR1 mutation in humans, which leads to increased susceptibility to mycobacterial infections, was paralleled by similar findings in mouse models (Filipe-Santos et al., 2006). These studies underscore the utility of forward genetics in identifying conserved genetic pathways that govern immune responses across species. \n\nReverse genetics, on the other hand, involves manipulating specific genes to observe phenotypic outcomes. While this approach has been invaluable in mice, its application in humans is limited due to ethical and technical constraints. Nonetheless, advances in CRISPR-Cas9 technology have begun to bridge this gap, allowing for precise genetic modifications in human cells and tissues (Doudna and Charpentier, 2014). This technology holds promise for validating findings from mouse models in human systems, thereby enhancing the translational potential of murine studies. \n\nThe genetic analysis of both mouse and human studies has revealed species-specific differences in immune responses that are often rooted in evolutionary pressures. For instance, the divergence in the immune response to viral infections between mice and humans can be attributed to differences in the selection pressures exerted by pathogens in their respective environments (Netea et al., 2016). These evolutionary insights are crucial for understanding why certain genetic mutations have different phenotypic outcomes in mice and humans. \n\nMoreover, the integration of genomic data from both species has facilitated the identification of genetic loci associated with immune-related traits. Genome-wide association studies (GWAS) in humans have identified numerous loci linked to immune function and disease susceptibility, many of which have orthologs in mice (Visscher et al., 2017). These findings highlight the potential for cross-species genetic studies to uncover conserved mechanisms of immunity. \n\nIn conclusion, reconciling mouse and human immunology requires a nuanced understanding of the genetic factors that influence immune responses. While species-specific differences pose challenges, the integration of genetic data from both models offers a powerful approach to uncovering the fundamental principles of immunity. By leveraging the strengths of both forward and reverse genetics, researchers can gain complementary insights into the mechanisms of immunity to infection, ultimately enhancing our ability to translate findings from mouse models to human health.", "References": [{"title": "Humanized mice in translational biomedical research", "authors": "Shultz, Leonard D., Ishikawa, Fumihiko, Greiner, Dale L.", "journal": "Nature Reviews Immunology", "year": "2007", "volumes": "7", "first page": "118", "last page": "130", "DOI": "10.1038/nri2017"}, {"title": "Of mice and not men: differences between mouse and human immunology", "authors": "Mestas, Javier, Hughes, Christopher C. W.", "journal": "The Journal of Immunology", "year": "2004", "volumes": "172", "first page": "2731", "last page": "2738", "DOI": "10.4049/jimmunol.172.5.2731"}, {"title": "Genomic responses in mouse models poorly mimic human inflammatory diseases", "authors": "Seok, Junhee, Warren, Harry S., Cuenca, Alexander G., Mindrinos, Michael N., Baker, Henry V., Xu, Weihong, Richards, David R., McDonald-Smith, Grace P., Gao, Hong, Hennessy, Lisa", "journal": "Proceedings of the National Academy of Sciences", "year": "2013", "volumes": "110", "first page": "3507", "last page": "3512", "DOI": "10.1073/pnas.1222878110"}, {"title": "Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes", "authors": "Casanova, Jean-Laurent, Holland, Steven M., Notarangelo, Luigi D.", "journal": "Current Opinion in Immunology", "year": "2013", "volumes": "25", "first page": "690", "last page": "702", "DOI": "10.1016/j.coi.2013.09.007"}, {"title": "The genetic basis of human inborn errors of immunity", "authors": "Cooper, Megan A., Pommering, Thomas L., Korányi, Kornélia", "journal": "Pediatric Clinics of North America", "year": "2015", "volumes": "62", "first page": "743", "last page": "765", "DOI": "10.1016/j.pcl.2015.04.001"}, {"title": "Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features", "authors": "Filipe-Santos, Olivier, Bustamante, Jacinta, Haverkamp, Martin H., Vinolo, Eliane, Ku, Chia-Lin, Puel, Anne, von Bernuth, Horst, Feinberg, Jacqueline, Durandy, Anne, Chrabieh, Maren", "journal": "Seminars in Immunology", "year": "2006", "volumes": "18", "first page": "347", "last page": "361", "DOI": "10.1016/j.smim.2006.07.010"}, {"title": "The new frontier of genome engineering with CRISPR-Cas9", "authors": "Doudna, Jennifer A., Charpentier, Emmanuelle", "journal": "Science", "year": "2014", "volumes": "346", "first page": "1258096", "last page": "", "DOI": "10.1126/science.1258096"}, {"title": "Trained immunity: a program of innate immune memory in health and disease", "authors": "Netea, Mihai G., Joosten, Leo A. B., Latz, Eicke, Mills, Kingston H. G., Natoli, Gioacchino, Stunnenberg, Hendrik G., O'Neill, Luke A. J., Xavier, Ramnik J.", "journal": "Science", "year": "2016", "volumes": "352", "first page": "aaf1098", "last page": "", "DOI": "10.1126/science.aaf1098"}, {"title": "10 years of GWAS discovery: biology, function, and translation", "authors": "Visscher, Peter M., Wray, Naomi R., Zhang, Qian, Sklar, Pamela, McCarthy, Mark I., Brown, Matthew A., Yang, Jian", "journal": "The American Journal of Human Genetics", "year": "2017", "volumes": "101", "first page": "5", "last page": "22", "DOI": "10.1016/j.ajhg.2017.06.005"}]}